Frontiers in Cardiovascular Medicine, Год журнала: 2024, Номер 11

Опубликована: Июль 26, 2024

Cardioneuroablation (CNA) is a novel interventional procedure for the treatment of recurrent vasovagal syncope (VVS) and advanced atrioventricular block secondary to hyperactivation vagal tone in young patients. By damaging cardiac parasympathetic ganglia, CNA seems be able mitigate and/or abolish excessive activity improve patients' outcome. This review intended give detailed comprehensive overview current evidences regarding (1) clinical applications (2) identification ablation targets procedural endpoints (3) medium-long term effect its future perspectives. However, data are still limited, expert consensus or recommendations guidelines this technique lacking.

Язык: Английский